Prothena Corporation plc Logo

Email this page: News Release

Prothena Announces Presentation of Clinical Data From the Ongoing Phase 1/2 NEOD001 Study and Systemic Amyloidosis Patient Survey Results at 20th Congress of the European Hematology Association

For security reasons, registration is required before you can use this feature.
* Indicates required field